Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2Phase 4 1Phase 2/3 1

Status

Recruiting 4Completed 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 8INDUSTRY 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Gastrointestinal 256Thoracic 101Breast 88CNS 83Head & Neck 72Sarcoma 56Gynecologic 46Genitourinary 39Dermatologic 28Endocrine 12Tumor-Agnostic 9Other solid neoplasm 5Other 2NET 2Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Neoplasms 5Neoplasm Metastasis 3Carcinoma 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Capecitabine 47Radiotherapy 46Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Tumor-Agnostic × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT01428895 2026-03-06

Femoral Bone Metastases

University Health Network, Toronto

Phase NA Active not recruiting
180 enrolled
Tumor-Agnostic

Neoplasms

NCT05717166 2025-12-31

SABR-SYNC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Recruiting
180 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06782451 2025-09-29

DST

Centre Antoine Lacassagne

Phase NA Recruiting
50 enrolled
Tumor-Agnostic

Neoplasms

NCT05301881 2025-02-05

COSMO

The Netherlands Cancer Institute

Phase 2 Recruiting
118 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

NCT02889718 2019-05-16

CONCERT

Institut Cancerologie de l'Ouest

Phase 2 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

NCT00003724 2016-07-12

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

Alliance for Clinical Trials in Oncology

Phase 3 Completed
530 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00902083 2012-04-09

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡